Arkolith/Insider Trading/CTXR/Form 4

Holubiak Myron Z

President and CEO, Director, 10% OwnerCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Jul 26, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 22, 2021Grant(A)300K—$0300K
Jul 22, 2021Grant(A)10K—$010K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-038696) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML